In 2006, Martinon et al. (Martinon et al. 2006) were the first to report that MSU crystals in the joints of patients with gout could activate NLRP3, thereby activating caspase-1 and promoting the maturation of IL-1β and IL-18. This evidence concerns the gene NLRP3 and gout.